Accelerated regulatory pathways are mechanisms designed to expedite the approval process of medical products, such as drugs and vaccines, particularly during public health emergencies. These pathways aim to address urgent medical needs by shortening the time required for regulatory review while maintaining safety and efficacy standards.
